tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Luca Issi, 83 are a HOLD (40.49%), 121 are a BUY (59.02%), 1 are a SELL (0.49%).
Analyst Luca Issi, currently employed at RBC, carries an average stock price target met ratio of 37.51% that have a potential upside of 32.58% achieved within 137 days.
Luca Issi’s has documented 398 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 18-Sep-2025.
Analyst best performing recommendations are on APLS (APELLIS PHARMACEUTICALS).
The best stock recommendation documented was for FDMT (4D MOLECULAR THERAPEUTICS ) at 1/29/2024. The price target of $25 was fulfilled within 7 days with a profit of $6.98 (38.73%) receiving and performance score of 55.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$8
2 months 6 days ago
(03-Aug-2025)
0/3 (0%)
$2.86 (55.64%)
Hold
$5
2 months 6 days ago
(03-Aug-2025)
1/7 (14.29%)
$3.06 (157.73%)
148
Buy
4 months 26 days ago
(13-May-2025)
2/9 (22.22%)
$12.2 (210.34%)
94
Buy
$10
4 months 26 days ago
(13-May-2025)
0/2 (0%)
$6.92 (224.68%)
Buy
$9
4 months 26 days ago
(13-May-2025)
2/8 (25%)
$6.54 (265.85%)
3
Which stock is Luca Issi is most bullish on?
Which stock is Luca Issi is most reserved on?
What Year was the first public recommendation made by Luca Issi?
